Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes

OBJECTIVE: Leucine-rich α-2 glycoprotein 1 (LRG1) was recently identified as an amplifier of transforming growth factor-β (TGF-β)–induced kidney fibrosis in animal models. We aimed to study whether urine LRG1 is associated with risk of progression to end-stage kidney disease (ESKD) in individuals wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian-Jun, Liu, Sylvia, Wang, Jiexun, Pek, Sharon L.T., Lee, Janus, Gurung, Resham L., Ang, Keven, Shao, Yi Ming, Tavintharan, Subramaniam, Tang, Wern Ee, Sum, Chee Fang, Lim, Su Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887617/
https://www.ncbi.nlm.nih.gov/pubmed/36516193
http://dx.doi.org/10.2337/dc22-1611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887617/
https://www.ncbi.nlm.nih.gov/pubmed/36516193
http://dx.doi.org/10.2337/dc22-1611

Ejemplares similares